64.40 USD
▼-0.78-1.20%
盘后 64.75 +0.54%
2026-09-15
市值
$207.70M
市盈率
—
EPS
-5.59
股息率
—
52 周区间
23.15 – 97.97
成交量
59.10K
Beta
1.13
目标价
196.67
52W 低 23.1552W 高 97.97
价格走势
公司简介
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-...